Pages that link to "Q71739769"
Jump to navigation
Jump to search
The following pages link to Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents (Q71739769):
Displaying 50 items.
- Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells (Q24672087) (← links)
- Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries (Q24678553) (← links)
- Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression (Q24685645) (← links)
- Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells (Q24806463) (← links)
- The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells (Q28198688) (← links)
- Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments (Q28345648) (← links)
- Controlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responses (Q28480895) (← links)
- A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development (Q28534459) (← links)
- Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments (Q30442799) (← links)
- Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme (Q30673942) (← links)
- p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers (Q33535200) (← links)
- Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1. (Q33538422) (← links)
- Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids (Q34060908) (← links)
- Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo (Q34103311) (← links)
- Pharmacological aspects of targeting cancer gene therapy to endothelial cells (Q34180767) (← links)
- p27 as a target for cancer therapeutics (Q34181774) (← links)
- Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation (Q34405013) (← links)
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer (Q34415244) (← links)
- Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis (Q34611577) (← links)
- Immunopathological prognostic and predictive factors in prostate cancer (Q35054043) (← links)
- The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy (Q35091146) (← links)
- Ovarian cancer: strategies for overcoming resistance to chemotherapy (Q35166813) (← links)
- Drug resistance and the microenvironment: nature and nurture (Q35214616) (← links)
- Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death (Q35567260) (← links)
- Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents (Q35663759) (← links)
- p27 deregulation in breast cancer: prognostic significance and implications for therapy (Q35745141) (← links)
- p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19 (Q35745855) (← links)
- Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival (Q35753209) (← links)
- Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases (Q35753378) (← links)
- Skp2 is oncogenic and overexpressed in human cancers (Q35862209) (← links)
- Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells (Q35865626) (← links)
- Tumour suppressor genes in chemotherapeutic drug response (Q36083098) (← links)
- p27Kip1 Is Required to Mediate a G1 Cell Cycle Arrest Downstream of ATM following Genotoxic Stress (Q36128510) (← links)
- Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review (Q36238230) (← links)
- Prognostic value of p27 kip1 expression in adenocarcinoma of the pancreatic head region (Q36253468) (← links)
- New insights into the kinetic resistance to anticancer agents (Q36254839) (← links)
- E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1) (Q36256290) (← links)
- A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation (Q36379218) (← links)
- Establishing a link between oncogenes and tumor angiogenesis (Q36438366) (← links)
- A cytosine analog that confers enhanced potency to antisense oligonucleotides (Q36441952) (← links)
- NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha. (Q36501960) (← links)
- p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome (Q36620425) (← links)
- Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells (Q36634119) (← links)
- Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. (Q36675710) (← links)
- Houttuynia cordata Thunb extract modulates G0/G1 arrest and Fas/CD95-mediated death receptor apoptotic cell death in human lung cancer A549 cells (Q36722711) (← links)
- Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer (Q36955104) (← links)
- Maytansinoid immunoconjugate IMGN901 is cytotoxic in a three-dimensional culture model of multiple myeloma (Q37019223) (← links)
- The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer (Q37194315) (← links)
- Environment-mediated drug resistance: a major contributor to minimal residual disease (Q37582773) (← links)
- Molecular predictive and prognostic markers in non-small-cell lung cancer. (Q37606747) (← links)